| MA | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 149.23 g/mol [1] |
| Predicted LogP | 2.1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C10H15N [1] |
| IUPAC name | N-methyl-1-phenylpropan-2-amine [1] |
| SMILES | CC(CC1=CC=CC=C1)NC [1] |
| InChI | InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3 [1] |
| InChIKey | MYWUZJCMWCOHBA-UHFFFAOYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 9 – 12 hours (range 5 – 30 hours); irrespective of route |
| Duration of action | 8 – 12 hours[4] |
Methamphetamine
Methamphetamine is a stimulant substance of the amphetamine class.
Chemistry
Stereochemistry []
Methamphetamine is a racemic mixture of the enantiomers
Pharmacology
Interactions
- CYP2D6 inhibition
- CYP2D6 induction
Subjective effects
| Anodyne Usernotes [] | |
|---|---|
| 0xea / Methamphetamine[hydrochloride] via Oral, Insufflated, Intrarectal, Subcutaneous, Intramuscular, Intravenous and Vaporized |
|
Legal status
- Australia: Methamphetamine is a S8 substance.
- Brazil: Methamphetamine is a F2 substance.[3]
- Canada: Methamphetamine is a Schedule I substance.
- Germany: Methamphetamine is a Anlage II substance.
- New Zealand: Methamphetamine is a Class A substance.
- United Kingdom: Methamphetamine is a Class A substance.
- United States: Methamphetamine is a Schedule I under the "Controlled Substances Act (CSA)".
- United Nations: Methamphetamine is a Schedule II substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 1206, DL-methamphetamine. Accessed November 9, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/1206
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Methamphetamine. UNII: 13ZT6YG5SD. Global Substance Registration System. Accessed November 9, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/13ZT6YG5SD
Anvisa. RDC Nº 804 – Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. Accessed November 9, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
Courtney KE, Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend. October 1, 2014; 143():11–21.
Anodyne